Perrigo | PRGO - Loan Capital


Perrigo reported $3.6B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Abbott USD 9.9B 1.7B Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Coherus Biosciences USD 51.08M 496K Dec/2025
Dr.Reddys Laboratories INR 11.61B 29M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merck USD 39.97B 6B Sep/2025
Nestle CHF 46.25B 742M Dec/2025
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi EUR 13.84B 1.88B Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025
Zoetis USD 9.04B 1.97B Dec/2025